Journal articles
A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine
L. Seguin
M. Chaffanet
1
R. Sabatier
1
A. Jose
1
S. Garnier
1
N. Carbuccia
1
A. Guille
1
D. Birnbaum
1
F. Bertucci
1
A. Goncalves
1
F. Bertucci 1
Author
A. Goncalves 1
Author
1
CRCM - Centre de Recherche en Cancérologie de Marseille (27 bd Leï Roure, BP 300059
13273 Marseille Cedex 09 - France)
- CNRS - Centre National de la Recherche Scientifique : UMR7258 (France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : U1068 (101, rue de Tolbiac, 75013 Paris - France)
- Institut Paoli-Calmettes : UMR7258 (France)
- AMU - Aix Marseille Université : UM105 (Aix-Marseille Université Jardins du Pharo 58 Boulevard Charles Livon 13284 Marseille cedex 7 - France)
Document type :
Journal articles
Domain :
Complete list of metadatas
https://hal-amu.archives-ouvertes.fr/hal-02143656
Contributor : Ghislain Bidaut <>
Submitted on : Wednesday, May 29, 2019 - 2:52:24 PM
Last modification on : Monday, August 31, 2020 - 9:52:06 AM
Contributor : Ghislain Bidaut <>
Submitted on : Wednesday, May 29, 2019 - 2:52:24 PM
Last modification on : Monday, August 31, 2020 - 9:52:06 AM
Links full text
Identifiers
- HAL Id : hal-02143656, version 1
- DOI : 10.1093/annonc/mdy314.030
Citation
L. Seguin, M. Chaffanet, R. Sabatier, A. Jose, S. Garnier, et al.. A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine. Annals of Oncology, Elsevier, 2018, 29 (6), ⟨10.1093/annonc/mdy314.030⟩. ⟨hal-02143656⟩
Metrics
Record views